DexCom Gains Pre-Market Traction on Financial Figures, Bullish Views
- July 28th, 2023
- 383 views
DexCom, Inc. (Nasdaq: DXCM) delivered strong results in the second quarter of 2023, with earnings per share (EPS) of $0.34 and revenues of $871.30 million, surpassing the consensus estimate of $0.23 EPS on revenue of $841.62 million.
In response to the robust performance, the company raised its fiscal full-year 2023 revenue guidance to between $3.50 billion to $3.55 billion, up from the previous range of $3.40 billion to $3.52 billion. Analysts had expected revenue of $3.50 billion for the period.
Furthermore, investment firms Baird and Raymond James upheld their positive outlook on DexCom. Baird maintained an Outperform rating and raised the price target from $145 to $153, while Raymond James maintained a Strong Buy rating and increased the price target from $140 to $154.
In pre-market trading, $DXCM surged by $4.95 (+3.83%) to reach $134.31.
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
September 18th, 2025
Crown Equity Holdings, Inc. Announces Letter of Intent with Stewart Holdings LLP
September 16th, 2025September 15th, 2025Crown Equity Holdings, Inc. Announces Letter of Intent with BioHarvest Naturals Corp.
September 15th, 2025Earnings Watch: FedEx, Darden Restaurants, and FactSet Gear Up
September 14th, 2025
Member Login